Science
New Glenn’s Third Mission Set for April 19 as Blue Origin Advances Commercial Space Capabilities
CAPE CANAVERAL, Fla. — Blue Origin has confirmed the launch window for the third mission of its heavy-lift New Glenn rocket, marking another step forward in the company’s expanding role in commercial spaceflight.
New Glenn’s Third Mission
Launch Details and Timeline
The mission is scheduled to lift off no earlier than Sunday, April 19, 2026, from Launch Complex 36 at Cape Canaveral Space Force Station. The two-hour launch window opens at 6:45 a.m. EDT (10:45 UTC) and closes at 8:45 a.m. EDT (12:45 UTC).
Viewers can follow the mission through a live webcast hosted by Blue Origin, beginning approximately 30 minutes before liftoff.
Mission Payload: Expanding Space-Based Connectivity
At the heart of the mission is the deployment of the BlueBird 7 satellite, developed by AST SpaceMobile. The satellite is designed to enhance a growing direct-to-smartphone broadband network, an emerging technology aimed at delivering connectivity to standard mobile devices without the need for ground-based towers.
BlueBird 7 will contribute to expanding network capacity and is expected to support initial service rollout plans targeted for 2026. The broader initiative reflects a significant shift in how satellite infrastructure could complement terrestrial telecom systems, particularly in underserved or remote regions.
Reusability Milestone: Booster Returns Again
A key feature of this mission is the planned reuse of New Glenn’s first-stage booster, “Never Tell Me The Odds.” The booster previously demonstrated a successful launch and landing during the rocket’s second mission in November, underscoring Blue Origin’s commitment to reusable rocket technology—a cornerstone of cost reduction and operational efficiency in modern spaceflight.
If successful, this mission will further validate the reliability of the New Glenn system and strengthen its competitiveness in a market increasingly shaped by reusable launch vehicles.
Industry Context: Competing in a Rapidly Evolving Market
The New Glenn program represents Blue Origin’s answer to heavy-lift launch demands, positioning the company alongside major players such as SpaceX. As satellite constellations grow in scale and ambition, reliable and cost-effective launch services have become a critical component of the global space economy.
The inclusion of commercial payloads like BlueBird 7 highlights the increasing collaboration between aerospace firms and telecommunications providers, signaling a future where space-based infrastructure plays a central role in everyday connectivity.
Looking Ahead
With its third mission, New Glenn continues to build momentum as a next-generation launch platform. The combination of reusable hardware, commercial partnerships, and advanced payload capabilities places this launch among the most closely watched developments in the 2026 spaceflight calendar.
For ongoing updates, mission tracking, and live coverage, audiences can follow Blue Origin across its digital platforms or visit its official website.
Source
Blue Origin Official Announcement – New Glenn Third Mission
Related External Links
- Learn More About Blue Origin’s New Glenn Rocket
- AST SpaceMobile – Space-Based Cellular Broadband Network
- Cape Canaveral Space Force Station Information
- NASA Overview of Low Earth Orbit (LEO) Operations
Explore the latest in innovation, AI, gadgets, startups, and digital trends in STM Daily News’ Techsection.
Last Updated on April 17, 2026 by Daily News Staff
Earth Day is celebrated annually on April 22nd, and it serves as a reminder of the importance of taking care of our planet. It’s a day to reflect on our impact on the environment and to take action to create a better future for our planet.
The first Earth Day was celebrated in 1970, and it marked the beginning of the environmental movement. Since then, Earth Day has grown into an international event, with millions of people around the world participating in activities and events to raise awareness about environmental issues.
One of the main goals of Earth Day is to encourage people to take action to reduce their impact on the environment. This can include simple actions like recycling, conserving energy, and reducing waste. It can also involve more significant actions like advocating for environmental policies and supporting sustainable businesses.
Another important aspect of Earth Day is education. It’s a time to learn about environmental issues and to understand how our actions can impact the planet. Many schools and organizations use Earth Day as an opportunity to teach children about the importance of taking care of the environment.
This year’s Earth Day theme is “Restore Our Earth”, and it focuses on the idea that we can all play a role in restoring the planet’s ecosystems. This can include actions like planting trees, reducing plastic waste, and supporting sustainable agriculture.
Earth Day is an important reminder of the impact that we have on the environment and the importance of taking action to create a better future for our planet. By working together and taking small steps, we can make a big difference in protecting the planet and ensuring that it remains healthy and beautiful for generations to come.
Earth Day – April 22
https://nationaltoday.com/earth-day/
https://stmdailynews.com/category/science/
Author
health and wellness
Cannabis Legalization Drives Innovation, Raises Health Concerns
Cannabis legalization is driving innovation, but much of it focuses on commercial products rather than patient health. New research highlights gaps between market growth and medical evidence.
Lucy Xiaolu Wang, UMass Amherst and Nathan W. Chan, UMass Amherst
Cannabis legalization
Innovation in health care saves lives. But not all health innovations have enough evidence to actually benefit patients.
Barriers to innovation are often higher in illicit or restricted markets, including cannabis, stem cells and cryptocurrencies. Researchers face higher costs, limited access to raw materials and data, and stricter regulations.
Cannabis illustrates a particularly confusing tension between regulatory restrictions on one hand and research and innovation on the other.
While the U.S. federal government still classifies cannabis as having “no accepted medical use,” many states have legalized it for medical or recreational use. Meanwhile, the Department of Health and Human Services obtained a cannabis-related patent in 2003 covering potential medical uses of cannabis compounds for protecting the brain from damage or degeneration. The patent was exclusively licensed for commercialization.
Research and innovation on cannabis can take many forms. Clinical trials may study cannabis products as medical treatments, the effects of cannabis on its users, or factors related to abuse and dependence. Meanwhile, cannabis-related patents can be filed for wide-ranging purposes, such as chemical formulations, methods for production or new consumer products like edibles, beverages or vaporizers.
But do these innovations actually benefit consumers and patients?
We are economists studying how institutional changes affect innovation in different markets. Our recently published research found that legalization of recreational cannabis use appears to spur innovation, but primarily in ways that expand commercial opportunities rather than scientific understanding or health benefits for patients.
Cannabis’ evolving legality in the US
Cannabis is a plant that contains chemical compounds called cannabinoids. One such compound, tetrahydrocannabinol, or THC, produces psychoactive effects, while another compound called cannabidiol, or CBD, is often used to relieve anxiety and pain. However, there has been insufficient evidence on how effective cannabis products are in treating medical conditions, as well as a lack of consistent medical and dosing guidance.
At the federal level in the U.S., cannabis has been classified as a Schedule I drug for over a half-century. This classification indicates that the federal government considers cannabis to have a high potential for abuse and no accepted medical use.
As a Schedule I drug, there are significant restrictions on cannabis research. Researchers who seek to conduct cannabis-related clinical trials must obtain approval from both the Food and Drug Administration and the Drug Enforcement Administration, a process that can take over a year. They are also limited to using select varieties of cannabis obtained from federally authorized cannabis suppliers, and are generally prohibited from studying products available in state-authorized markets.
There are ongoing pushes to relax these restrictions. Meanwhile, cannabis has been legalized to varying extents in many states. California became the first state to pass a medical cannabis law in 1996, allowing qualified patients to grow, possess and use cannabis for medical purposes. Many states followed suit in the late 1990s and early 2000s. As of June 2025, 40 states allow medical cannabis use.
A number of states also allow recreational or nonmedical cannabis use among adults, which is regulated in similar ways to alcohol. Colorado and Washington enacted the first recreational cannabis laws in 2012, and there are 24 states that permit adults to use cannabis recreationally as of January 2026.
Altogether, the legal landscape for cannabis in the U.S. has varied considerably across states and over time. States with more permissive laws can lower the costs of medical research and product development with cannabis, even if federal drug scheduling continues to restrict access. For instance, one group of Washington State University researchers asked participants to independently purchase and smoke cannabis from a legal dispensary before returning to their lab for study.
State legalization and cannabis innovation
To systematically examine how state legalization affects cannabis-related innovation, we compiled and analyzed datasets tracking cannabis-related clinical trials and patent applications.
We distinguished different types of cannabis-related innovation. Specifically, we categorized cannabis-related clinical trials based on whether they focused on its potential as a treatment, its usage and effects, or its role in drug abuse. Similarly, we categorized cannabis-related patents based on whether they focused on chemical compounds, medical uses, methods or products.
We also assessed public health concerns across three measures: patents explicitly involving THC; patents with a high risk of misuse; and patents targeting consumers directly, such as high-potency formulations, edibles or vaporizers.
Then, we compared changes in cannabis-related innovation over time in states that legalized cannabis earlier with those in states that did so later or not at all. We measured innovation by counting the number of cannabis-related clinical trials and patent filings. We distinguished between medical and recreational legalization to assess how different policies affect innovation.
Overall, we found that when states legalize cannabis for recreational use, cannabis-related patents increase – but mostly in commercial-oriented areas rather than health-focused ones. Patents were concentrated in market-oriented innovations like cultivation equipment and consumer products, rather than in clinical or science-based research. We also found some evidence that these innovations may raise public health concerns.
Legalization did not result in meaningful increases in clinical trials. This suggests that barriers to cannabis-related clinical research – such as limited access to research-grade cannabis, limited funding and stigma around working with a federally controlled substance – remain substantial.
Gaps between research and product
As 420 – signifying April 20, a day celebrating cannabis culture – approaches each year, public attention turns toward the legal status of cannabis.
The legal landscape has evolved rapidly over the past few decades, and further changes are in the pipeline. Both the Biden and second Trump administrations have made efforts to reclassify cannabis as a Schedule III substance, which would indicate that it has an accepted medical use and low-to-moderate potential for dependence.
These reevaluations of the legality of cannabis come at a critical time. There has been an explosion of recreational cannabis products in recent years, including increasingly potent strains and a wider variety of ways to use cannabis. Meanwhile, critical research on the health and safety of cannabis use has lagged due to heavy restrictions accompanying Schedule I status.
This gap between medical research and product innovation can have significant public health consequences. The 2019 to 2020 outbreak of lung injuries related to e-cigarette or vape use was linked partly to the use of unregulated or illicit cannabis vaping products. These harms highlight the risks of allowing product innovation for controlled substances to outpace scientific understanding.
Policies that significantly reduce obstacles to clinical research can in turn help close the widening gap between cannabis markets and addressing their public health implications.
Lucy Xiaolu Wang, Assistant Professor of Resource Economics, UMass Amherst and Nathan W. Chan, Professor of Resource Economics, UMass Amherst
This article is republished from The Conversation under a Creative Commons license. Read the original article.
STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.
Tech
Drones paired with AI could help search‑and‑rescue teams find missing persons faster
AI-powered drones equipped with thermal and infrared imaging are transforming search-and-rescue operations, enabling teams to locate missing persons faster and assess their condition—including signs of injury, consciousness, or life-threatening temperature changes—in real time.
Adeel Khalid, Kennesaw State University
A combination of infrared imaging, thermal imaging and color cameras on an uncrewed drone, along with an AI system to interpret the data, can help emergency responders and search-and-rescue teams locate, identify and track people who have gone missing in the wilderness. The experimental system helps responders pinpoint where a missing person is and determine whether they are hurt or even alive.
People who get lost or hurt while exploring nature can become stranded for days. Rescue teams often use drones to look for the person or signs of their whereabouts. The small drone my colleagues and I built at my lab at Kennesaw State University flies autonomously using a grid search pattern. It sends live video and images to a ground station operated by the rescue team.
When the AI system finds a person, it analyzes images to determine whether the individual is upright or lying on the ground. It segments parts of the person’s body, identifying the person’s head and the body’s position. It then zeroes in on the forehead. It extracts forehead temperature readings, pixel by pixel, from the imaging data to estimate forehead temperature. We have two papers detailing these findings accepted for the American Institute of Aeronautics and Astronautics Aviation Forum 2026 conference.
Our AI model then assesses whether the person is conscious or unconscious and identifies abnormal temperatures that could indicate heat stress, hypothermia or other physical complications, or death – all vital information for a search-and-rescue team.
In field trials we have conducted, the system has provided consistent temperature readings of the heads of volunteers from our research team who have walked out into a variety of environments, under different conditions.
Why it matters
It is critical to get accurate and timely information on the whereabouts of a missing person. The likelihood that the person will survive decreases steeply as time passes.
An AI-enhanced drone can make search-and-rescue operations significantly more efficient than sending teams of people out into the environment to search on foot, especially in poor weather conditions or under thick foliage. Rescuers who know whether a person is conscious or unconscious can also better gear up for what they need to do to retrieve the person and administer aid. Our technology could save lives.
What other research is being done
Search-and-rescue personnel use various kinds of drones, but the machines often lack the ability to positively identify humans, especially under thick foliage, in bad weather or when the person is lying down or unconscious. The AI-based technology we have developed overcomes those challenges.
Better sensors that are very lightweight, that can function at night or in rain, and can see more clearly through thick foliage could further improve our drone and drones used by others. Researchers are devising AI-powered sound recognition for detecting screams for help, advanced thermal imaging for better nighttime vision and autonomous drones that could act as first responders.
Also under development are drones that can carry heavy payloads, such as flotation devices, fly for up to 14 hours or perform real-time mapping of the ground below.
What’s next
One of our next steps is to have multiple drones fly together and autonomously coordinate search-and-rescue operations among themselves. This will allow the technology to cover a much larger area, perhaps hundreds of square miles.
We are also designing a large drone that can carry up to 110 pounds (50 kilograms) of payload and stay aloft for an hour.
The Research Brief is a short take on interesting academic work.
Adeel Khalid, Professor of Industrial & Systems Engineering, Kennesaw State University
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Looking for an entertainment experience that transcends the ordinary? Look no further than STM Daily News Blog’s vibrant Entertainment section. Immerse yourself in the captivating world of indie films, streaming and podcasts, movie reviews, music, expos, venues, and theme and amusement parks. Discover hidden cinematic gems, binge-worthy series and addictive podcasts, gain insights into the latest releases with our movie reviews, explore the latest trends in music, dive into the vibrant atmosphere of expos, and embark on thrilling adventures in breathtaking venues and theme parks. Join us at STM Entertainment and let your entertainment journey begin! https://stmdailynews.com/category/entertainment/
and let your entertainment journey begin!
